Authors:
PREVOST G
BENAMOUZIG R
VEBER N
FAJAC A
TATOUD R
DEGEORGES A
EDEN P
Citation: G. Prevost et al., THE SOMATOSTATIN RECEPTOR SUBTYPE-2 IS EXPRESSED IN NORMAL AND TUMORAL HUMAN TISSUES, Cancer detection and prevention, 21(1), 1997, pp. 62-70
Authors:
PREVOST G
VEBER N
VIOLLET C
ROUBERT V
ROUBERT P
BENARD J
EDEN P
Citation: G. Prevost et al., SOMATOSTATIN-14 MAINLY BINDS THE SOMATOSTATIN RECEPTOR SUBTYPE-2 IN HUMAN NEUROBLASTOMA TUMORS, Neuroendocrinology, 63(2), 1996, pp. 188-197
Authors:
PLANCHON P
VEBER N
MAGNIEN V
ISRAEL L
STARZEC AB
Citation: P. Planchon et al., ALTERATION OF PROSTAGLANDIN-E RECEPTORS IN ADVANCED BREAST-TUMOR CELL-LINES, Molecular and cellular endocrinology, 111(2), 1995, pp. 219-223
Authors:
PLANCHON P
VEBER N
MAGNIEN V
PREVOST G
STARZEC AB
ISRAEL L
Citation: P. Planchon et al., EVIDENCE FOR SEPARATE MECHANISMS OF ANTIPROLIFERATIVE ACTION OF INDOMETHACIN AND PROSTAGLANDIN ON MCF-7 BREAST-CANCER CELLS, Life sciences, 57(12), 1995, pp. 1233-1240
Citation: N. Veber et al., EVIDENCE FOR A GROWTH EFFECT OF EPIDERMAL GROWTH-FACTOR ON MDA-MB-231BREAST-CANCER CELLS, European journal of cancer, 30A(9), 1994, pp. 1352-1359
Authors:
PREVOST G
BOURGEOIS Y
MORMONT C
LERRANT Y
VEBER N
POUPON MF
THOMAS F
Citation: G. Prevost et al., CHARACTERIZATION OF SOMATOSTATIN RECEPTORS AND GROWTH-INHIBITION BY THE SOMATOSTATIN ANALOG BIM23014 IN SMALL-CELL LUNG-CARCINOMA XENOGRAFT- SCLC-6, Life sciences, 55(2), 1994, pp. 155-162
Authors:
STARZEC AB
SPANAKIS E
NEHME A
SALLE V
VEBER N
MAINGUENE C
PLANCHON P
VALETTE A
PREVOST G
ISRAEL L
Citation: Ab. Starzec et al., PROLIFERATIVE RESPONSES OF EPITHELIAL-CELLS TO 8-BROMO-CYCLIC AMP ANDTO A PHORBOL ESTER CHANGE DURING BREAST PATHOGENESIS, Journal of cellular physiology, 161(1), 1994, pp. 31-38